Systemic antibacterial activity of novel synthetic cyclic peptides. - Test2 - elhamkhani - TriplyDB

Systemic antibacterial activity of novel synthetic cyclic peptides.

Systemic antibacterial activity of novel synthetic cyclic peptides.

http://www.wikidata.org/entity/Q33220464

about

A synthetic chloride channel relaxes airway smooth muscle of the rat De novo design and synthesis of ultra-short peptidomimetic antibiotics having dual antimicrobial and anti-inflammatory activities.Synthesis and combinational antibacterial study of 5''-modified neomycin.Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides.Synergy among antibacterial peptides and between peptides and small-molecule antibiotics.Limiting an antimicrobial peptide to the lipid-water interface enhances its bacterial membrane selectivity: a case study of MSI-367 Expedient Synthesis of SMAMPs via Click Chemistry.Bead diffusion assay for discovering antimicrobial cyclic peptides.Guanidino groups greatly enhance the action of antimicrobial peptidomimetics against bacterial cytoplasmic membranes Self-assembling peptide nanotubes with antiviral activity against hepatitis C virus Novel approaches to flavivirus drug discovery.Antifungal amphiphilic aminoglycoside K20: bioactivities and mechanism of action.Iterative antimicrobial candidate selection from informed d-/l-Peptide dimer libraries.The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation.Antitumor and antimicrobial activity of some cyclic tetrapeptides and tripeptides derived from marine bacteria.Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.Infectious Disease: Connecting Innate Immunity to Biocidal Polymers.Anti-microbial, anti-biofilm activities and cell selectivity of the NRC-16 peptide derived from witch flounder, Glyptocephalus cynoglossus.Antibacterial properties and mode of action of a short acyl-lysyl oligomer.De novo designed synthetic mimics of antimicrobial peptides.Antibacterial cyclic D,L-alpha-glycopeptides killerFLIP: a novel lytic peptide specifically inducing cancer cell death.Fungal cyclooligomer depsipeptides: from classical biochemistry to combinatorial biosynthesis.Beta-peptoid "foldamers"--why the additional methylene unit?Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.Transmembrane delivery of anticancer drugs through self-assembly of cyclic peptide nanotubes.Self-assembled peptide nanomaterials for biomedical applications: promises and pitfalls.Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines.A combinatorial approach to the discovery of biocidal six-residue cyclic D,L-alpha-peptides against the bacteria methicillin-resistant Staphylococcus aureus (MRSA) and E. coli and the biofouling algae Ulva linza and Navicula perminuta.Cell-penetrating peptide and antibiotic combination therapy: a potential alternative to combat drug resistance in methicillin-resistant Staphylococcus aureus.Self-Assembling Cyclic d,l-α-Peptides as Modulators of Plasma HDL Function. A Supramolecular Approach toward Antiatherosclerotic Agents.Synthetic mimics of antimicrobial peptides from triaryl scaffolds Mechanisms mediating bactericidal properties and conditions that enhance the potency of a broad-spectrum oligo-acyl-lysyl.Activities of antimicrobial peptides and synergy with enrofloxacin against Mycoplasma pulmonis.Similarity analysis, synthesis, and bioassay of antibacterial cyclic peptidomimetics.Chemical space guided discovery of antimicrobial bridged bicyclic peptides against Pseudomonas aeruginosa and its biofilms.Design, crystal structure and atomic force microscopy study of thioether ligated d,l-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa.New antimicrobial peptide kills drug-resistant pathogens without detectable resistance.Synthesis, biological activity and conformational analysis of head-to-tail cyclic analogues of LL37 and histatin 5.

P2860

Q28484047-8B5B5B59-A7F3-4993-90F3-20060FEC84E9 Q31145703-D3E70DE2-27CE-4793-BE2E-7445BE368D86 Q33486457-6E343D32-36AE-462D-AEEA-834383D5CA14 Q33496543-C211AF9A-540B-49CE-9333-B9B41562A0C1 Q33593511-4FC55BBB-DF36-4710-9493-58F749D6CB1B Q33742617-7F584682-6AA6-4A5D-810C-C3FC9CD36DA8 Q33749813-7B9A5E9E-6EF6-4564-B028-AA5982B231BB Q33770348-90D6F56C-2EC7-4C23-81E2-16F5500B4742 Q34017067-F41BEDD9-0B3C-4040-8F0E-1BC5F55D83E3 Q34084050-D8185281-802D-4641-BAD7-43DFD3D8C8F4 Q34206832-DACE9796-FCB6-4D35-B7CC-34FC6F344AE4 Q34637793-A4B463E1-A213-4BD3-831E-0EAC618519B6 Q35024514-CDF67D1E-32B1-445B-88F2-BAD72B8BFDF4 Q35297286-B7BAFC43-283B-4C12-A79E-CFEF8E002592 Q35657498-0E237FDD-7A70-4C53-9632-F30B3B939368 Q35987945-21ACE452-F495-4F21-9934-F97BCC5CDA39 Q36018591-238A2815-F2F9-4319-B371-8AEDF434535E Q36298207-229CF760-B160-4A96-9811-D403C057E382 Q37040038-3932D5CA-70CD-4521-A069-639299FE2F11 Q37274674-96BFFFB5-D086-4878-8E9B-86117AC21921 Q37321460-7CDE3EE8-D5C1-4137-BAE4-E2F762DDB70A Q37379417-6F01F565-8847-4D53-AC23-5D5CD5AEEC8E Q37577463-6C980DE2-9FEE-4EBD-9CCC-A1C1AB754C76 Q37801553-E80A3C71-80EA-4E47-BB6A-C80FA695EF9D Q37823878-BEDAF1EA-D775-4124-BC10-07FE9248E471 Q38137920-B18F38DA-3F4F-4FFB-A9FE-4C9D4AFB1A24 Q38787285-99AD6F3D-6002-49A8-9C79-6EAA3ABAF1EF Q39067679-446D7C49-B4C6-4D7B-89B6-0BD553300F43 Q39203205-4BE1BDBB-5F18-47EA-9782-52BC0B624D7E Q39923401-CFD9C8D6-042A-4567-945F-5FE72F2CA69D Q40808308-79F0ED38-14EE-4A7F-8D16-7FADF886486C Q40993177-17C4C05A-7D70-4EF0-B66B-F004E72AFF03 Q41916979-C55234E9-6A62-4D7D-B1A8-6C9C1C14BED8 Q42041041-9A19B942-6808-4705-8B92-47004B1C18CE Q42112297-B4963A2F-D95D-468A-BC32-7808101944E7 Q42611602-3A4D0CFA-D9D7-45B9-9BCB-9D125BB229C5 Q44157129-06A0FCD2-E60C-4C6F-9CB3-6CA8B37B7342 Q47325287-4E7F4F41-B3D7-4B04-8343-ACB5259B5A96 Q52592867-1CCDB4DE-9146-4704-86E1-4F4C9598F815 Q53157658-C53BDDC6-F481-46F0-83BE-846665D178BE

P2860

Systemic antibacterial activity of novel synthetic cyclic peptides.

http://www.wikidata.org/entity/Q33220464

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Systemic antibacterial activity of novel synthetic cyclic peptides.

@ast

Systemic antibacterial activity of novel synthetic cyclic peptides.

@en

type

label

Systemic antibacterial activity of novel synthetic cyclic peptides.

@ast

Systemic antibacterial activity of novel synthetic cyclic peptides.

@en

prefLabel

Systemic antibacterial activity of novel synthetic cyclic peptides.

@ast

Systemic antibacterial activity of novel synthetic cyclic peptides.

@en

P1433

Q33220464-90C988EF-BB00-4F54-A266-7F79AD6AE514

P1476

Q33220464-951736B8-1C56-4499-AE89-283D4FA86C91

P2093

Q33220464-0DFE7984-B37D-4E8F-B5DE-F3042712957E

Q33220464-12034F2B-427D-4638-82F1-C817E60F0FCA

Q33220464-14B3C021-EE88-45E8-98FF-A2ECD6A9E553

Q33220464-4E187E86-4E40-46E6-AA83-B41F4AA93E45

Q33220464-5E0F6334-AA58-482B-B3E5-B67B7535B92D

Q33220464-6293D6AB-A7E8-463E-8558-5EA8C3B17FB4

Q33220464-7D530AFC-7C09-4038-B4CE-FD9EC6547009

Q33220464-7F9782A1-EF67-434C-A5E6-A4E7A322EC50

Q33220464-908E67ED-B4BB-4F2E-B6C2-3ACE5E8975A0

Q33220464-ABBF975F-A782-4098-A0BC-C91CCFD398F7

P2860

Q33220464-07AA83BE-B168-488E-8468-467AC3021764

Q33220464-0B6829DB-C0A8-4539-ACBC-949BBA3D37B8

Q33220464-1283DD06-A75F-4B65-AF11-31F4772EAB63

Q33220464-18740293-14DC-432A-B1E0-E854F9B83DF0

Q33220464-3786E182-76C5-4395-95C6-2D1EBC18AB55

Q33220464-41550324-B995-4B26-9FF9-B8EEC6EAD39E

Q33220464-47A4EB58-A7BA-42AC-AD58-F9867B2BF55D

Q33220464-47B0BED9-0195-4365-92D5-DEB6F24A9FEC

Q33220464-54CA5641-E061-4FFD-8E79-3880B5702F95

Q33220464-5E629E42-C464-40A6-9570-8336B6F0411A

P304

Q33220464-A53D3966-8736-402F-9A80-F5F92ABAFE04

P31

Q33220464-14666A43-7817-4B51-8F6D-F0299987DB0C

P356

Q33220464-2D4AA4B8-A55B-486A-BF69-E27CCB36D44B

P407

Q33220464-4170283E-1506-4F12-AD41-74B221BA5283

P433

Q33220464-CE663263-53C5-4244-A96A-20A343860D9E

P478

Q33220464-3D65515B-F955-43ED-996D-C8850F1C1B9A

P50

Q33220464-AF39CED6-2040-4CE1-B97E-0D208C4CEE3E

P577

Q33220464-1D825C3B-4AD8-418A-A93B-1B6F16C656BC

P698

Q33220464-E13F6145-FD98-4217-B0FA-FCAC350968CE

P932

Q33220464-C9B9D47A-1D01-4DB4-8368-CB690C34C63E

P356

AAC.49.8.3302-3310.2005

P1433

Antimicrobial Agents and Chemotherapy

P1476

Systemic antibacterial activity of novel synthetic cyclic peptides.

@en

P2093

Carrie Dunn

http://www.w3.org/2001/XMLSchema#string

Chad Dubbelde

http://www.w3.org/2001/XMLSchema#string

Colleen Gritzen

http://www.w3.org/2001/XMLSchema#string

Dana Weinberger

http://www.w3.org/2001/XMLSchema#string

Edelmira Cabezas

http://www.w3.org/2001/XMLSchema#string

Ellen Chi

http://www.w3.org/2001/XMLSchema#string

Jorge Sanchez-Quesada

http://www.w3.org/2001/XMLSchema#string

M Reza Ghadiri

http://www.w3.org/2001/XMLSchema#string

Thomas R Parr

http://www.w3.org/2001/XMLSchema#string

Véronique Dartois

http://www.w3.org/2001/XMLSchema#string

P2860

Staphylococcus aureus infections

Reactions of glutamate 1-semialdehyde aminomutase with R- and S-enantiomers of a novel, mechanism-based inhibitor, 2,3-diaminopropyl sulfate

A one-bead, one-stock solution approach to chemical genetics: part 2.

Automated mass spectrometric sequence determination of cyclic peptide library members.

Antimicrobial resistance trends and outbreak frequency in United States hospitals.

Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides.

Staphylococcus aureus resistant to vancomycin--United States, 2002.

An overview of nosocomial infections, including the role of the microbiology laboratory.

Cationic antimicrobial peptides - an update.

Methicillin-resistant Staphylococcus aureus infections in ICU patients.

P304

3302-3310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.49.8.3302-3310.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16048940

http://www.w3.org/2001/XMLSchema#string

P932

1196229

http://www.w3.org/2001/XMLSchema#string